Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-026779

CFO sold 45,000 shares at an average $107.69 ($4,846,016)

  • CFO acquired 45,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Burrell Terry-Ann CFO 2021-06-28 Option exercise +45,000 $13.68 $615,600 69,809 D
Burrell Terry-Ann CFO 2021-06-28 Sale −1,100 $103.86 $114,246 68,709 D
Burrell Terry-Ann CFO 2021-06-28 Sale −1,880 $104.63 $196,704 66,829 D
Burrell Terry-Ann CFO 2021-06-28 Sale −5,220 $105.34 $549,875 61,609 D
Burrell Terry-Ann CFO 2021-06-28 Sale −8,907 $106.13 $945,300 52,702 D
Burrell Terry-Ann CFO 2021-06-28 Sale −3,290 $107.20 $352,688 49,412 D
Burrell Terry-Ann CFO 2021-06-28 Sale −4,803 $108.45 $520,885 44,609 D
Burrell Terry-Ann CFO 2021-06-28 Sale −19,800 $109.41 $2,166,318 24,809 D
Derivatives
Burrell Terry-Ann CFO 2021-06-28 Option exercise · Stock Option (Right to Buy) −45,000 312,941 D
Open-market sales · 45,000 sh · avg $107.69 · $4,846,016
Loading xslF345X03/doc4.xml…